---
figid: PMC5058685__oncotarget-07-30350-g007
figtitle: Hypermethylated in cancer 1(HIC1) suppresses non-small cell lung cancer
  progression by targeting interleukin-6/Stat3 pathway
organisms:
- NA
pmcid: PMC5058685
filename: oncotarget-07-30350-g007.jpg
figlink: /pmc/articles/PMC5058685/figure/F7/
number: F7
caption: HIC1 expression is impaired in NSCLC due to the hypermethylation modification,
  leading to the higher secretion of IL-6. Autocrine of IL-6 can activate JAK/STAT3
  pathway and the expression of downstream targets, such as MMP2, Bcl-2 and Survivin,
  therefore promoting NSCLC progression.
papertitle: Hypermethylated in cancer 1(HIC1) suppresses non-small cell lung cancer
  progression by targeting interleukin-6/Stat3 pathway.
reftext: Xiumin Wang, et al. Oncotarget. 2016 May 24;7(21):30350-30364.
year: '2016'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9317751
figid_alias: PMC5058685__F7
figtype: Figure
organisms_ner:
- Danio rerio
- Homo sapiens
redirect_from: /figures/PMC5058685__F7
ndex: 49bb768f-dee9-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5058685__oncotarget-07-30350-g007.html
  '@type': Dataset
  description: HIC1 expression is impaired in NSCLC due to the hypermethylation modification,
    leading to the higher secretion of IL-6. Autocrine of IL-6 can activate JAK/STAT3
    pathway and the expression of downstream targets, such as MMP2, Bcl-2 and Survivin,
    therefore promoting NSCLC progression.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - jak2b
  - stat3
  - il6
  - stat1b
  - stat4
  - hic1
  - hic1l
  - chmp2a
  - birc5a
  - mmp2
  - JAK2
  - STAT3
  - IL6
  - SOAT1
  - STAT1
  - STAT2
  - STAT4
  - STAT6
  - STAT5A
  - STAT5B
  - HIC1
  - BCL2
  - MMP2
---
